FDA Drug Application (020261) for LESCOL by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number020261
Product Number001
FormCAPSULE;ORAL
DosageEQ 20MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLESCOL
Active IngredientFLUVASTATIN SODIUM

Active IngredientCount
List of drugs with Active Ingredient FLUVASTATIN SODIUM3


Back to FDA Applications sponsored by NOVARTIS